US National TOP Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTransMedics

About this trial

The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • OCS Lung

Treatment groups

10,000 Participants
are divided into 2 treatment groups

Locations

7
Arizona
St. Joseph's Hospital & Medical Center85013, Phoenix United States
California
Stanford University School of Medicine94305, Stanford United States
Minnesota
University of Minnesota55455, Minneapolis United States
North Carolina
Duke University27705, Durham United States

Sponsors and collaborators

TransMedics

Lead sponsor